HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ajay Kirtane Selected Research

ST Elevation Myocardial Infarction

1/2019Association of Physician Variation in Use of Manual Aspiration Thrombectomy With Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: The National Cardiovascular Data Registry CathPCI Registry.
9/2017Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United States.
6/2017Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trials.
12/2016Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States.
11/2016Is multivessel intervention in ST-elevation myocardial infarction associated with early harm? Insights from observational data.
5/2014Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS.
12/2013Variability in maximal suggested door-in-door-out time for hospitals transferring patients for primary angioplasty in STEMI.
11/2010Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
4/2006Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardial infarction: the Swedish Early Decision (SWEDES) reperfusion trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ajay Kirtane Research Topics

Disease

9ST Elevation Myocardial Infarction
01/2019 - 04/2006
8Hemorrhage
01/2020 - 10/2010
7Myocardial Infarction
01/2022 - 04/2009
6Thrombosis (Thrombus)
07/2020 - 02/2008
5Hypertension (High Blood Pressure)
01/2021 - 08/2015
5Heart Failure
11/2019 - 01/2018
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 02/2008
4Stroke (Strokes)
01/2022 - 10/2018
4Acute Coronary Syndrome
07/2015 - 10/2010
3Diabetes Mellitus
11/2019 - 11/2010
3Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 10/2010
2Atrial Fibrillation
10/2020 - 10/2018
2Aortic Valve Stenosis (Aortic Stenosis)
01/2020 - 01/2017
2Cardiogenic Shock
11/2018 - 07/2015
2Infarction (Infarctions)
06/2017 - 04/2006
2Acute Kidney Injury (Acute Renal Failure)
06/2015 - 01/2013
2Ischemia
12/2013 - 10/2010
1COVID-19
07/2020
1Clinical Deterioration
11/2018
1Peripheral Arterial Disease
10/2018
1Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
01/2018
1Embolic Stroke
06/2014
1Death (Near-Death Experience)
05/2014
1Heart Arrest (Cardiac Arrest)
02/2014
1Aneurysm (Aneurysms)
02/2008

Drug/Important Bio-Agent (IBA)

5Heparin (Liquaemin)FDA LinkGeneric
07/2020 - 10/2010
4bivalirudin (Angiomax)FDA Link
09/2017 - 10/2010
4MetalsIBA
10/2012 - 02/2008
3AnticoagulantsIBA
09/2017 - 10/2010
2Glycoproteins (Glycoprotein)IBA
09/2017 - 10/2010
2Pharmaceutical PreparationsIBA
10/2012 - 11/2010
1Fibrinolytic Agents (Antithrombotic Agents)IBA
07/2020
1Angiotensin Receptor AntagonistsIBA
01/2020
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2020
1Mineralocorticoid Receptor AntagonistsIBA
11/2019
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
10/2018
1CalciumIBA
01/2017
1ReninIBA
11/2015
1Antihypertensive Agents (Antihypertensives)IBA
11/2015
1SodiumIBA
11/2015
1thienopyridineIBA
07/2015
1Adenosine Diphosphate (ADP)IBA
12/2013
1thiazole-4-carboxamide adenine dinucleotide (TCAD)IBA
10/2012
1Insulin (Novolin)FDA Link
11/2010
1Paclitaxel (Taxol)FDA LinkGeneric
11/2010
1Platelet Membrane Glycoprotein IIbIBA
10/2010
1IsoenzymesIBA
04/2009
1Creatine Kinase (Creatine Phosphokinase)IBA
04/2009
1Abciximab (ReoPro)FDA Link
04/2006
1reteplaseFDA Link
04/2006
1Enoxaparin (Lovenox)FDA LinkGeneric
04/2006

Therapy/Procedure

14Percutaneous Coronary Intervention
01/2022 - 04/2006
9Stents
11/2016 - 02/2008
8Therapeutics
01/2020 - 04/2006
6Drug-Eluting Stents
01/2022 - 02/2008
6Transcatheter Aortic Valve Replacement
01/2020 - 01/2013
5Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2022 - 10/2010
4Denervation
01/2021 - 08/2015
3Heart-Assist Devices
12/2018 - 11/2018
2Patient Readmission
01/2020 - 01/2019
1Artificial Respiration (Mechanical Ventilation)
10/2020
1Thrombectomy
01/2019
1Cardiopulmonary Bypass (Heart-Lung Bypass)
01/2018
1Length of Stay
01/2018
1Catheters
07/2016
1Ablation Techniques
11/2015
1Extracorporeal Membrane Oxygenation
07/2015
1Blood Transfusion (Blood Transfusions)
06/2015
1Embolic Protection Devices
06/2014
1Resuscitation
02/2014
1Time-to-Treatment
12/2013